Three of the market’s most closely watched space and eVTOL companies — Rocket Lab, AST SpaceMobile, and Archer Aviation — are set to report their second-quarter results after the U.S. market closes today, within roughly ninety minutes of each other. The reports follow a sharp sector-wide recovery over the past week, reversing the “SpaceX Effect” that had pressured these stocks through July. Now, each company must justify the bounce with its own specific milestones, which could break the thematic correlation that has tied them together.
Rocket Lab (RKLB): The stock, currently at $82.83, is 57% below its all-time high of $151. While analysts expect revenue of about $231.6 million (up ~60% year over year) and a narrow loss, the real focus is on commentary around the Neutron rocket. Neutron is central to Rocket Lab’s major Space Force contracts — including a $397 million deal for advanced flat satellites and a $266 million contract for suborbital launches — yet it has not flown. Any update on Neutron’s development timeline, as well as integration details for the recently acquired Iridium communications business, Mynaric, and Motiv, will likely move the stock more than the quarterly numbers. Options markets are pricing a post-earnings move of about 15.7%.
AST SpaceMobile (ASTS): This company is building a space-based cellular network to connect ordinary smartphones directly to satellites. Its valuation hinges on deployment speed and cash runway, not current revenue. Investors will closely watch the pace of BlueBird satellite launches and the company’s cash position. With nearly 60 carrier partners and billions of potential subscribers, the demand side is strong, but execution and funding are binary catalysts. ASTS recently rebounded from the mid-$50s to around $72.
Archer Aviation (ACHR): As a pre-commercial electric air taxi maker, Archer’s quarterly financials matter less than progress toward FAA certification. The company has reiterated its goal of initial U.S. operations in 2026, and tonight’s update on certification milestones will be the key variable. The stock recovered from the mid-$4s to near $5.60, and its wide valuation spread reflects the high stakes of regulatory approval.
The simultaneous reporting creates a unique risk for thematic-ETF or basket-CFD holders, as three unrelated catalysts — a rocket’s flight readiness, a satellite constellation’s build rate, and an aircraft’s certification — will now price independently. The correlation that lifted the group this past week could quickly fragment, turning diversification into exposure to three separate binary events.
